Filings & corporate actions
- 31 JulresultsResults · Q1 FY27 · consolidated and standalone-5.4%NSE
- 17 JuldividendDividend · ₹4.50 per share-0.3%
- 14 JulshareholdingShareholding · 30 Jun 2026-1.5%NSE
- 22 MayresultsResults · Q4 FY26 · consolidated and standalone+4.5%NSE
- 23 AprshareholdingShareholding · 31 Mar 2026-0.7%NSE
- 13 FebresultsResults · Q3 FY26 · consolidated and standalone+0.9%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-2.3%NSE
Reaction to results · all yearsrose on day 0 in 23 of 45 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 31 Jul 2026 | -5.4% | -9.6% | -6.0% | 5.8× |
| Q4 FY26 | 22 May 2026 | +4.5% | +4.2% | +3.9% | 4.7× |
| Q3 FY26 | 13 Feb 2026 | +0.9% | +2.7% | -8.9% | 1.2× |
| Q2 FY26 | 14 Nov 2025 | +14.5% | +12.7% | +8.4% | 44.8× |
| Q1 FY26 | 1 Aug 2025 | -6.0% | -9.2% | -7.0% | 4.2× |
| Q4 FY25 | 26 May 2025 | -1.9% | -1.4% | +11.9% | 1.2× |
| Q3 FY25 | 14 Feb 2025 | -0.1% | +4.9% | +23.8% | 1.1× |
| Q2 FY25 | 31 Oct 2024 | -1.9% | +1.4% | -0.1% | 1.1× |
| Q1 FY25 | 2 Aug 2024 | -0.7% | -1.7% | +3.6% | 1.3× |
| Q4 FY24 | 24 May 2024 | -1.3% | -5.6% | -5.1% | 1.1× |
| Q3 FY24 | 14 Feb 2024 | -4.5% | -3.3% | -12.8% | 3.1× |
| Q2 FY24 | 14 Nov 2023 | +4.5% | +14.8% | +9.2% | 7.2× |
| Q1 FY24 | 3 Aug 2023 | +0.7% | -2.5% | +1.0% | 2.5× |
| Q4 FY23 | 20 May 2023 | +7.5% | +11.2% | +30.1% | 15.2× |
| Q3 FY23 | 9 Feb 2023 | -0.4% | +0.4% | +8.7% | 4.8× |
| Q2 FY23 | 10 Nov 2022 | +3.7% | +1.3% | +2.5% | 5.5× |
| Q1 FY23 | 9 Aug 2022 | +3.3% | +9.2% | +7.0% | 8.4× |
| Q4 FY22 | 20 May 2022 | -4.4% | +1.0% | -3.8% | 0.9× |
| Q3 FY22 | 4 Feb 2022 | +2.4% | -0.2% | -0.7% | 1.4× |
| Q2 FY22 | 10 Nov 2021 | +4.4% | +7.8% | +5.3% | 29.8× |
| Q1 FY22 | 5 Aug 2021 | +7.4% | -1.0% | +4.6% | 8.3× |
| Q4 FY21 | 31 May 2021 | +12.4% | +10.0% | +10.0% | 25.1× |
| Q3 FY21 | 5 Feb 2021 | -3.1% | -7.9% | -18.1% | 0.9× |
| Q2 FY21 | 2 Nov 2020 | +0.9% | +0.6% | +16.8% | 2.0× |
| Q1 FY21 | 4 Aug 2020 | +0.1% | +13.9% | +11.5% | 1.9× |
| Q4 FY20 | 15 Jun 2020 | -2.5% | -6.9% | -2.6% | 1.6× |
| Q3 FY20 | 31 Jan 2020 | -4.5% | -6.2% | -15.2% | 1.5× |
| Q2 FY20 | 8 Nov 2019 | +5.1% | +9.2% | +12.1% | 10.4× |
| Q1 FY20 | 9 Aug 2019 | +7.7% | +7.0% | +13.0% | 19.7× |
| Q4 FY19 | 24 May 2019 | +14.1% | +18.1% | +24.2% | 6.9× |
| Q3 FY19 | 1 Feb 2019 | +0.8% | +1.6% | +17.9% | 0.5× |
| Q2 FY19 | 21 Nov 2018 | +2.0% | -4.5% | -12.2% | 0.3× |
| Q1 FY19 | 14 Aug 2018 | -1.9% | -2.1% | +0.5% | 0.3× |
| Q4 FY18 | 25 Jun 2018 | -0.5% | +0.6% | +7.8% | 0.2× |
| Q3 FY18 | 5 Feb 2018 | -1.2% | +6.2% | -0.6% | 3.3× |
| Q2 FY18 | 9 Nov 2017 | +1.3% | +1.8% | -2.9% | 0.4× |
| Q1 FY18 | 21 Aug 2017 | -1.2% | +3.4% | +2.7% | 1.0× |
| Q4 FY17 | 10 Jun 2017 | +1.3% | -4.3% | -8.4% | 1.7× |
| Q3 FY17 | 2 Feb 2017 | -0.2% | -0.9% | -4.2% | 4.4× |
| Q2 FY16 | 11 Nov 2016 | -3.6% | -0.4% | -1.5% | 0.8× |
| Q2 FY17 | 11 Nov 2016 | -3.6% | -0.4% | -1.5% | 0.8× |
| Q1 FY17 | 5 Oct 2016 | +0.7% | +2.1% | +0.1% | 0.2× |
| Q1 FY16 | 5 Oct 2016 | +0.7% | +2.1% | +0.1% | 0.2× |
| Q4 FY16 | 31 May 2016 | -1.4% | 0.0% | +0.3% | 0.2× |
| Q3 FY16 | 9 Feb 2016 | -3.6% | -12.9% | -11.9% | 0.8× |
| Average | +1.0% | +1.5% | +2.5% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSV| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +33.0% | +24.3% | +23.7% | +24.4% | +22.1% | +17.2% |
| Profit | +0.6% | +6.3% | +21.4% | +35.1% | — | +36.2% |
Key data
CSVDelivery percentage
Over the last 20 sessions NH settled 53.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 53.6%. The latest session ranks higher than 46% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.08% | -5.29% | -8.42% | -13.92% | +6.08% | -0.07% |
Valuation
CSVOwnership
CSVQuarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 1,643.8 | 2,151.2 | 2,593.8 | 2,683.6 |
| YoY chg | +17.4% | +57.4% | +75.8% | +78.0% |
| Net profit (₹ Cr) | 258.5 | 126.8 | 224.0 | 207.3 |
| YoY chg | +30.0% | -34.3% | +13.5% | +5.4% |
| Net margin | 15.7% | 5.9% | 8.6% | 7.7% |
| EPS | 12.72 | 6.24 | 11.02 | 10.20 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 63.27% · public 36.11%- Promoter
- Public and others
- Promoter
- 63.27%
- Public
- 36.11%
- Promoter change
- 0.00 pp
- Filed
- 14 Jul 2026
- FII
- 9.40%
- DII
- 9.06%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,305.2 | 1,203.6 | 1,279.4 | 1,341.0 | 1,400.0 | 1,366.7 | 1,475.4 | 1,507.3 | 1,643.8 | 2,151.2 | 2,593.8 | 2,683.6 | |
| Other income | 18.4 | 17.9 | 23.9 | 23.5 | 23.6 | 18.4 | 26.8 | 23.8 | 24.0 | 23.2 | 29.2 | 35.5 | |
| Total income | 1,323.6 | 1,221.5 | 1,303.3 | 1,364.4 | 1,423.6 | 1,385.0 | 1,502.3 | 1,531.1 | 1,667.8 | 2,174.4 | 2,623.0 | 2,719.1 | |
| Total expenses | 1,075.3 | 1,012.9 | 1,077.7 | 1,132.8 | 1,191.8 | 1,166.2 | 1,240.9 | 1,299.8 | 1,371.0 | 1,971.2 | 2,328.9 | 2,456.8 | |
| └ Finance costs | 22.9 | 25.1 | 28.0 | 34.0 | 35.1 | 36.6 | 40.7 | 45.2 | 42.3 | 65.0 | 91.3 | 86.8 | |
| └ Depreciation | 55.3 | 63.2 | 64.8 | 61.7 | 65.1 | 70.0 | 82.5 | 84.3 | 87.5 | 122.3 | 153.8 | 156.1 | |
| Profit before tax | 248.4 | 208.6 | 225.6 | 231.7 | 231.8 | 218.8 | 253.0 | 231.3 | 296.8 | 152.2 | 294.1 | 262.3 | |
| Tax expense | 21.7 | 20.5 | 34.8 | 30.2 | 33.0 | 25.8 | 56.8 | 34.8 | 37.2 | 22.3 | 64.1 | 53.1 | |
| Net profit | 226.7 | 188.1 | 190.8 | 201.5 | 198.8 | 193.1 | 197.3 | 196.7 | 258.5 | 126.8 | 224.0 | 207.3 | |
| EPS | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.50 | 9.71 | 9.68 | 12.72 | 6.24 | 11.02 | 10.20 | |
| Net margin | 17.37% | 15.63% | 14.91% | 15.03% | 14.20% | 14.13% | 13.37% | 13.05% | 15.73% | 5.89% | 8.64% | 7.72% | |
| PBT margin | 19.03% | 17.33% | 17.63% | 17.28% | 16.56% | 16.01% | 17.15% | 15.34% | 18.05% | 7.08% | 11.34% | 9.77% | |
| Tax rate | 8.74% | 9.82% | 15.44% | 13.03% | 14.23% | 11.77% | 22.44% | 15.04% | 12.53% | 14.63% | 21.79% | 20.25% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 31 Jul 2026.
NH at a glance
- NH closed at ₹1,723.8 on 6 Oct 2026, +0.08% on the day, -0.1% over one year, 17.7% below its 52-week high of ₹2,093.3.
- Delivery was 53.4% of traded quantity on 6 Oct 2026, the 46th percentile of its own 1,731 sessions with a reading (20-session average 53.2%, 1-year average 53.6%).
- Market capitalisation is ₹35,228 crore at a trailing P/E of 43.1 (trailing EPS ₹39.96).
- Q1 FY27 results (consolidated, filed 31 Jul 2026): revenue ₹2,684 crore (+78.0% year on year), net profit ₹207 crore (+5.4%); the price moved -5.4% on the first session after.
- Promoters held 63.27% at 30 Jun 2026, unchanged on the previous filing.
- Q2 FY27 results are expected between 31 Oct 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVPrices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- MEDANTAGlobal Health Limited1,300.80-2.39%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE